Home [sandbox] K4D COVID-19 Resource Hub Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses